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Government roles in regulating medical
tourism: evidence from Guatemala
Ronald Labonté1,5* , Valorie A. Crooks2, Alejandro Cerón Valdés3, Vivien Runnels1 and Jeremy Snyder4
Abstract
Background: Regulation of the medical tourism and public health sectors overlap in many instances, raising
questions of how patient safety, economic growth, and health equity can be protected. The case of Guatemala is
used to explore how the regulatory challenges posed by medical tourism should be dealt with in countries seeking
to grow this sector.
Methods: We conducted a qualitative case study of the medical tourism sector in Guatemala, through reviews and
analyses of policy documents and media reports, key informant interviews (n = 50), and facility site-visits.
Results: Key informants were critical of the absence of effective public regulation of the emerging medical tourism
sector, noting several regulatory gaps and the importance of filling them. These informants specifically expressed
that: 1) The government should regulate medical tourism in Guatemala, thought there was disagreement as to
which government sector should do so and how; 2) The government has not at this time regulated the medical
tourism sector nor shown great interest in doing so; and 3) International accreditation could be used to augment
domestic regulation.
Conclusions: The intersection of domestic and international regulation of medical tourism has been largely
unexplored. This case study advances new research in this area. It highlights the need for and dearth of regulatory
protections in Guatemala and lessons for other, similarly situated countries. National regulatory models from Israel
and Barbados could be adapted to the Guatemalan context. Global governance could help to protect national
governments from any competitive disadvantages created by regulation. Underlying the concerns over growth in
medical tourism, however, is how it contributes to the ongoing privatization of health care facilities worldwide. This
trend risks undermining efforts to reach targets for Universal Health Coverage and exacerbating existing inequities
in the global distribution of health and wealth.
Keywords: Medical tourism, Guatemala, Regulation, Health equity
Background
Medical tourism remains an industry that is predomin-
antly a commercial response to a demand or health care
driven by consumers. We use the term ‘medical tourism’
in a somewhat restrictive fashion: the self-selected
decision of individuals to seek medical care in a foreign
country. We thus exclude from our consideration ill and
injured vacationers, expats living much of their time
abroad and intermittently needing medical care, and
publicly-insured cross-border care initiated or approved
by governments, generally due to lack of or undersupply
within their own borders. While robust data with regard
to medical tourism is hard to come by, the medical tour-
ism industry lays claim to significant growth in recent
years, and associated with this growth a promise of
economic benefit. This benefit is arguably the key driver
of medical tourism on the supply side, and is recognized
as such by many countries seeking to develop or expand
this offshoring sector [1, 2]. Not only are many national
governments supportive of medical tourism, they are
also often investors in this sector [3, 4].
* Correspondence: rlabonte@uottawa.ca
1Globalization and Health Equity Research Unit, Faculty of Medicine,
University of Ottawa, Ottawa, Canada
5School of Epidemiology and Public Health, University of Ottawa, Alta Vista
Campus, 600 Peter Morand Crescent, Room 205A, Ottawa, ON K1G 5Z3,
Canada
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Labonté et al. International Journal for Equity in Health  (2018) 17:150 
https://doi.org/10.1186/s12939-018-0866-1
Although medical tourism can help to fill unmet
health care access needs for citizens of smaller countries
lacking higher-end treatment facilities, it has also been
criticized for poor safety standards and infection control,
and provision of illegal, unethical, or questionable proce-
dures [5–7]. This raises health and safety concerns as
well as ethical ones; as a 2013 United Kingdom (UK)
study noted, there is “currently no guidance or regula-
tion on risk or safety for UK residents who consider
travelling abroad for treatment” [8]. Others point out
that there is a “lack of robust clinical governance
arrangements and quality assurance procedures in
provider organisations” [9]. A decade ago the situ-
ation was summed up succinctly: regulation to protect
medical tourists’ health is needed [10]; while govern-
ments offering such services need to regulate the in-
dustry “to ensure the net effects for their [own]
citizens is positive” [11]. Regulation here, and as we
use the term throughout this article, refers to any
form of enforceable government measure “designed to
influence business or social behaviour” extending to
rules governing “all forms of social or economic influ-
ences” [12]; as well as to voluntary or self-regulated
systems. The primary areas in which medical tourism
and governmental (public) health care regulation
intersect include:
• Education and regulation of health professionals,
with concerns that both of these may be
sub-standard in destination countries to those in
countries of international patients [13],
• Changes in a destination country’s accreditation sys-
tems to accommodate internationally trained pro-
viders working in medical tourism facilities could
lower qualification standards [14, 15].
• Accreditation of health care facilities, with concerns
over inadequate governmental standards, or of
government oversight [16] of the over 40 private
international accreditation bodies [17].
• Provision of services that are illegal in the
international patient’s home country, and/or are
unproven or ineffective treatments [18, 19].
• The role of unregulated or self-regulated intermediary
medical tourism services, such as medical tourism
brokers, on-line sites, or specialized training
programs or certifications in medical tourism that
exist outside of publicly regulated professions [20].
• Potential lack of legal redress in cases of alleged
medical malpractice, where destination countries
may have no, or inadequate, means for international
patients to pursue claims [21, 22].
• Lack of requirements for the full sharing of medical
files/records, either by the international patient on
departure, or by the medical tourism provider on the
patient’s return [6, 23].
• Poor oversight of the potential spread of extreme
drug resistant or antimicrobial resistant infections
that international patients may return with, which
can then spread to health care facilities in their
home country especially if they require follow-up
care [24].
• The intersect between national-level policies and
regulations (or lack thereof ) and international law,
notably core human rights obligations that require
governments to ensure that privatization of health
markets (including those for medical tourism) or
actions of third parties (such as medical tourism
brokers) do not interfere with the right of na-
tional citizens to health care and health-related
services [25, 26].
As part of a multi-country study of the health equity
impacts of medical tourism in the Latin American and
Caribbean (LAC) region, in this article we examine how
different stakeholder groups considered government regu-
lation in one of our case-study countries (Guatemala),
which has been attempting in recent years to ‘grow’ this
health care sector.
We begin this article by providing some context on
our case-study country and then outline our study
methods. We next present findings from our study
pertinent to issues of regulation, touching on many of
the themes identified from the broader literature and
some of our earlier studies (above). We conclude with
some of the transferable implications of the Guatemalan
case for other governments growing this offshoring
health care sector, before making an argument for the
importance of locating future research on the health
equity implications of medical tourism (including studies
on regulation) within a political economy and global
governance framework.
Context
Guatemala is a poor country, ranking low on the Human
Development Index (125th out of 188 countries) [27]
with a per capita GNI of $3,790 [28], or US$7,297 when
adjusted for purchasing power parity (PPP) [29], a com-
monly employed international comparator. Although
this puts Guatemala in the World Bank’s grouping of
lower-middle income countries [28], it has comparatively
high levels of inequality and poverty for the Latin
American and Caribbean region [30]. Guatemala has a
2013 Gini coefficient for income distribution of 0.59,
indicative of grossly inequitable distribution at a scale
associated with increased risk of political and economic
instability [31].
Guatemala’s poverty and inequality are reflected in the
country’s total per capita expenditure on health, which
stood at $476 (Intl $) in 2014 [29]. Approximately 17.8%
(2014) of government expenditure is on health, a low
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amount compared against international and regional
levels [32], and accounts for just 2.3% of GDP. Private
health expenditure, by contrast, accounts for 3.9% of
GDP, of which 83.7% is out-of-pocket [33]. Guatemala’s
private health sector is noted as being highly unregu-
lated and fragmented while its public health sector is
under-resourced with unequally distributed delivery of
services [33]. It has a low density of health human
resources, with most physicians located in the urban
areas of Guatemala City. Indigenous peoples experience
higher levels of poverty and lower access to health care
than the non-Indigenous population [30, 33].
Although facing issues in ensuring a reasonable level
of domestic health care access, Guatemala is also one of
the more recent countries in the region to begin pro-
moting its medical tourism sector. Private organizations
including hospitals, hotels, health professionals, and
others have organized to form medical tourism clusters
[34], and have linked to other organizations with inter-
ests in trade, tourism, and medical tourism sectors, such
as the Guatemalan Association of Exporters (AGEX-
PORT) [33]. At present the number of medical tourists
seeking care in Guatemala is reported to be low, with no
facilities as yet focusing solely, or even primarily, on
international medical patients; plans for this expansion,
however, have been mooted [33]. Many current
Guatemalan medical tourists are from the diaspora, with
additional patients coming from proximate countries in
the region, although medical tourism providers are keen
to attract non-diaspora international patients from the
United States (US) and Canada. Individual private care fa-
cilities, currently serving primarily local patients (insured
or, more often, paying out of pocket) are looking to
medical tourism to fill unused capacity [35, 36], similar to
how medical tourism developed in Thailand [4], and what
we noted during site-visits in India [33, 37]. Some newer
Guatemalan facilities have business models premised on
increasing international patient flows to levels far exceed-
ing current numbers, raising questions about sustainability
of the industry [34, 35].
Methods
This analysis contributes to an exploratory case study
that examined potential and realized impacts of the
development of medical tourism in the LAC region on
health equity (with a focus on public and private health
care, health human resources, investment, and domestic
government involvement). Our case study included
reviews and analyses of policy documents and media
reports pertaining to Guatemala’s growing sector [33],
which provided detailed contextual information on the
country’s health system (reported above), and its limited
forays into medical tourism development, but focused
extensively on key informant interviews and health care
facility site-visits.
Working in partnership with local research collabora-
tors, recruitment of key informants for interviews was
undertaken using a purposeful strategy with a focus on
identifying information-rich perspectives. Potential par-
ticipants were identified through media searches, reviews
of relevant policy documents, and through the networks
of our local non-governmental organization collaborator.
Following the design of the multi-country study, we
sought target numbers of key informants from each of
five sectors identified as having interests in medical tour-
ism: health human resources representatives (e.g.
medical educators, health workers) from both public and
private universities and health care sectors (n = 15),
government representatives responsible for promoting
medical tourism and/or regulating health systems (e.g.
policy officials) (n = 15), public sector representatives
(e.g. hospital administrators, tourism planners) promot-
ing or potentially impacted by growth in the medical
tourism sector (n = 15), private sector representatives
(e.g., private clinic owners, private investment consul-
tants, medical tourism investors) with economic interest
in growth in the medical tourism sector (n = 15), and
civil society representatives (e.g., community groups,
media representatives) engaged in consultations and/or
reporting on medical tourism development in terms of
its economic or health equity outcomes (n = 15). To
protect anonymity in the context of a focused study
with s small, saturated sample, we do not provide a
further breakdown of participants to avoid identifying
individuals.
A total of 50 in-person semi-structured interviews
were conducted over a seven-month period, June to De-
cember 2013. Our background contextual study [33] was
used to identify areas were we could probe deeper for
elaboration of responses to our interview schedule.
Participants were recruited by phone or e-mail as appro-
priate and were identified following our review of
relevant policy and media documents as well as reviews
of human resources profiles for publicly-accessible
agencies. All interviews were conducted in the cities of
Antigua Guatemala or Guatemala City, which are the
focus of medical tourism sector development in the
country. Interviews lasted 45–90 min and were con-
ducted in Spanish by a research associate and research
assistant hired by our local collaborator. The interview
guide was semi-structured and pertained a series of
questions common across all participants as well as
questions that relate to specific areas of domain expert-
ise. Questions elicited stakeholders’ views/perspectives
on issues pertaining to the health equity concerns of
focus, including on domestic governments’ roles in
regulating medical tourism.
Labonté et al. International Journal for Equity in Health  (2018) 17:150 Page 3 of 10
All interviews were digitally recorded. Upon comple-
tion they were translated into and transcribed in English.
Upon completion the interviews being simultaneously
transcribed-translated into English. Our on-site collabo-
rators oversaw this process to ensure the integrity of the
transcripts, and served as a reference point for the tran-
scriptionists when assistance was needed. Interview texts
were thematically coded and analyzed for descriptive
findings related to the roles and implications of govern-
ment in the regulation of medical tourism. Numerous
rounds of independent transcript review, coding extract
review, and team meetings were conducted in order to
confirm the coding scheme, scope of this analysis, and
interpretation of the findings.
Qualitative rigour in this study was established
through investigators’ familiarity with the Guatemalan
context and the interview transcripts. There was team
discussion and agreement on the interpretation of the
participants’ perspectives presented in this paper.
Throughout the study, investigators maintained a critical
and reflective perspective on data interpretation in order
that investigator knowledge and standpoints did not
skew the participants’ perspectives reported in the paper.
Team leaders also took multiple steps to share findings
and invited critical feedback and commentary from a
wide variety of audiences. The study protocol was
ethically approved by ethics review boards at both Simon
Fraser University, British Columbia, and University of
Ottawa, Ontario.
Results
In our multi-country study of medical tourism in the
LAC region, Guatemala is one of the countries that
provided considerable data related to issues associated
with regulating medical tourism. It is more of a negative
case, insofar that our key informants were critical of the
current absence of effective public regulation, noting
several gaps and the importance of filling them. Some of
the regulatory gaps they describe exist within the public
health system as well as affecting the private medical
tourism sector, suggesting a weak overall health care
regulatory regime within the country.
Government should regulate medical tourism in Guatemala
Informants were in widespread agreement that it was
government’s responsibility to regulate medical tourism
in terms of accreditation of facilities. Private sector ac-
tors and those involved in the industry itself, however,
tended to favour self-regulation over government
intervention once facilities were approved. Moreover, the
question of which government sector should be respon-
sible for what aspects of regulation remained moot. One
government official maintained that overall government
responsibility for the regulation of medical tourism
should rest with the Ministry of Economy, since medical
tourism lies within the private business sector:
…Every private establishment of health and every
clinic [offering medical tourism]…should have
permission and mercantile registrations if they are big
hospitals, and all those types of things that are
regulated by the Ministry of Economy. The technical
(health) part (is) the responsibility of the Health
Ministry and its directorate of regulation, surveillance
and control of health, and its department of
regulation of health establishments, [and they] should
generate all the process of the establishment’s
accreditations, and generate permissions so that the
establishments can operate, [with] constant
supervision and monitoring.
The Ministry of Health thus retains certain regulatory
authority over medical tourism relative to professional
licensure, facilities accreditation, and monitoring of
services for health care quality control. This separation
of the business or trade regulatory side of medical
tourism from that of the health care regulation, as one
private health care provider noted, can advantage
medical tourism sector developers in terms of obtaining
promotional support from non-health affiliated minis-
tries, such as the Ministry of Economy and the Ministry
of External Relations. It was thought inappropriate (if
not politically unwise) for a health ministry in a poor
country with an underfunded public health system to be
seen promoting a private sector system serving wealthier
international patients.
Opinion on this division of regulatory responsibilities,
however, was itself divided, with one health professional
clearly expressing that “medical tourism is not a
physician business, it’s a corporate business” while
another was adamant that “It [the Ministry of Health]
should be regulating the whole system including the pri-
vate sector.” Some informants further suggested that the
costs of procedures charged to medical tourists should
also be regulated by the health ministry.
Regardless of which branch of government should lead
on medical tourism regulation, opinion on the import-
ance of such regulation was a frequent refrain. One of
the principle reasons was to ensure quality service to
international patients, partly because, as this health
professional stated, “someone can come have a surgery
with anyone, have a complication and never come back.”
According to this informant, to avoid this the
Guatemalan government must have clearer rules as to
“who can and who can’t treat these patients.” Secondly,
as one public health professional voiced a concern
expressed by several others, government regulation was
important “not just because of the sanitary [safety/
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quality] topic, but also because of the taxes.” As this
informant went on to explain, medical tourism needs to
be “done right, for the benefit of the country”, noting that
“these people [international patients, medical tourism
facilities] are taking - actually using - the infrastructure
of the country: airport, services, etc.” Taxation measures,
it was argued, were one essential measure that could
ensure that medical tourism is giving something back to
citizens of the country.
But there is a lack of effective regulation
While informants made clear the need for government
regulation of the medical tourism sector, they also noted
Guatemala’s lack of interest in prioritizing regulation:
“This role isn’t and, historically it hasn’t been, a priority
for governments.” Frequent change of officials or ruling
parties in Guatemala was also seen as stalling any
forward movement on regulatory reform. Informants
further reported on the general disorganization of the
Guatemalan health system, including weak regulation in
the public health sector, “a total deficiency of regulation”,
with implications for whether, or how well, regulation
might extend to the medical tourism sector. The poor
state of health regulation in Guatemala, generally,
prompted one health system expert informant to suggest
that it is creating a free-for-all for private health care
development, including medical tourism: “The Ministry
has been…weak as to regulating itself in the services it
provides and to regulate the private sector in the health
field…everyone wins from whatever they want.”
In response to being asked “is there a possibility for
medical tourism to grow without regulation?” another
informant drew on examples of other of the country’s
regulated industries:
Yes, without a doubt…it would be like the telephone
companies or the credit card companies or insurance
companies where they have minimum regulations and
they do whatever they want. And since we are talking
about commercial conditions not the conditions of
the services provided or the quality of the services, of
course anything can grow here.
This ‘anything goes’ sense of regulatory indifference to
or ineffectiveness of private health sector regulation is
also seen as an outcome of incoherence within how
health regulations come about within the country. As a
government official noted:
The legal part that constructs the health system in the
country [is] …complicated because… new legislation,
policies, and rules get added… sometimes…contrary
to rules and regulations that already exist. This
generates conflict in the operational part because
everyone looks out for themselves and they say ‘the
law says this or the law says that.’
As the above quote suggests, Guatemala’s chaotic
legislative system creates contradicting rules that can be
ignored or selectively invoked, allowing medical tourism
to grow unimpeded by the few health care regulations
that might apply. Despite some concern expressed about
this confusing state of “over-regulation in some ele-
ments,” there was also an observed lack of regulation in
other important components of health care (e.g. training
of health human resources, institutional standard
setting, and practices) which have direct relevance to
medical tourism facilities. As a health system expert in-
formant noted, there is a pressing need for an overhaul
of legislation, and subsequent enforcement:
Universities that “produce” human resources for
health should come up with a vision and a system for
accreditation, regulation, and certification because the
tendency in the country is that new schools of
medicine and new schools of nursing are opened, but
none of them is measured by any existing standards.
Because those standards do not exist.
This statement refers to the post-2000 growth in
new private medical and nurse training institutions;
most physicians still graduate from the public univer-
sity [33], although competition from private facilities
has begun to challenge the public system’s educational
dominance.
Regulation or international accreditation?
Informants implicitly made distinctions between na-
tional (governmental) regulation, which would include
accreditation of facilities and training programs, and
international accreditation, primarily for health care
facilities trying to attract international patients and the
qualifications of the medical staff working there. Most
emphasized the importance of international accredit-
ation as a demonstration of the quality standards of care,
which they saw as important in the promotion of
medical tourism. As one government official said:
People who come here for the first time on their own,
expect more guarantees for the medical service… And
the first thing…is the qualification of the medical staff.
So the international recognition of the doctors and
the institutions are really important, this international
recognition is given throughout accreditations, like
the Joint Commission [International] for health
services, or any other accrediting organization. And
this is the first variable that the client from another
country will look at.
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The high cost of international facility accreditation
was also acknowledged, but was seen as a necessary
investment to promote sustainable growth in medical
tourism, as a health professional working in this sector
in Guatemala explained:
If you want to get accredited, you will have to spend
some money, you will have to make an investment,
but you will have a better clinic, you will have
something better to give the people. And this will
reflect because people will come more. This way we
will be able to grab that market. But if you are not
accredited, which is the international norm, how can
you do it? [G]etting accredited is very expensive and it
takes a very long time [but] the expensive thing is not
to pay for the [accreditation].
Even accepting that the costs of international accredit-
ation were simply the price of admission into the global
medical tourism marketplace, there remained some
worry over the implications for health equity within
Guatemala itself. As one of our local health professionals
cautioned: “If you focus too much on meeting the inter-
national standards, you might leave behind what matters
in your own country; because you don’t worry about
things that happen here.”
Discussion
Our informants considered it government’s responsibil-
ity to prepare and coordinate the conditions for medical
tourism, including provision of regulatory structures to
ensure the quality, safety, and sustainability of this health
care sector. Although the Guatemalan government is
reportedly interested in supporting medical tourism for
economic development purposes, informants expressed
concern that its involvement and support for the health
care side of the industry was limited. Informants’ views
of the government’s roles in public health regulation
generally offered little assurance that Guatemala would
soon initiate actions in any of the problematic regulatory
areas intersecting medical tourism and public health
care, as outlined in our Introduction.
Guatemala is not alone in this regard. Findings from
our other studies exploring medical tourism sector de-
velopment in the LAC region have demonstrated similar
tension between the potential for regulation and the will
to actually regulate, including in Barbados [14], Jamaica
[38], St. Lucia [39], and Cayman Islands [40]. Although
our Guatemalan informants generally recognized the
need for governments to regulate public health care,
opinions on regulation of medical tourism were mixed.
Government informants argued that private medical
tourism facilities should be regulated in the same fashion
as public health facilities. Those working in the private
medical tourism sector were content with government
licensing of their facilities, and fiscal incentives to grow
the industry, but otherwise preferred self-regulation.
Although some working in this sector believed that
international accreditation (e.g. through JCI [Joint Com-
mission International] a private sector accreditation
body, [41]), would be an important signal of high quality
care, others remained more sceptical of the value of such
accreditation.
National governance (regulatory) models
There are nonetheless national regulatory models that
could be adopted in Guatemala, or other countries
pursuing medical tourism. One example is Israel, with a
mixed public/private system that reportedly receives
30,000 medical tourists annually, mostly from Russia,
Ukraine, Eastern Europe and Cyprus [42]. This practice
raised domestic complaints commonly heard in other
countries developing this industry: that the fees charged
international patients are higher than those paid by Is-
raeli citizens, potentially encouraging hospitals to prefer-
ence such patients over locals. In May 2017, Israel
passed legislation to prevent this. Although still wanting
to increase medical tourism for the revenues and foreign
currency it brings, it has now imposed several regulatory
requirements:
• Care for Israelis must not be harmed, and should
ideally improve.
• Income generated through medical tourism (includ-
ing taxation revenues) will be directed to strengthen-
ing the public health system.
• Hospitals must develop data monitoring systems for
governments to track the economic activities of
hospitals providing care to international patients, to
ensure revenues are remitted to the state, as well as
monitoring the quality of care received by inter-
national patients.
• Limits will be set on the number of international
patients each hospital can treat based on waiting
times and capacities.
• Intermediaries promoting or brokering medical
tourism services must register and abide a list of
required policies and practices [43].
How successful such regulations prove in achieving
their intent is for future study; but prima facie they
address many of the regulatory concerns posed by re-
searchers and health care scholars noted in the introduc-
tion to this article. Our research in other LAC region
countries, notably Barbados, which is in a similarly early
phase of medical tourism development to Guatemala
[44], has identified other potential regulatory directions.
For example, our focus groups with Barbadian lawyers
about the legal and regulatory implications of an ex-
panded medical tourism sector in that country showed
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the importance of taking measures with regard to immi-
gration law, physician licensing, corporate ownership
structures, and reputational protection.
A difference between Barbados and Guatemala, how-
ever, and between both LAC region countries and Israel,
is the capacity of their respective governments to
legislate and enforce regulatory measures. There are
inevitably costs associated with establishing and funding
new regulatory regimes [45]. Such a regime could be
financed through taxes on medical tourism (Israel’s
policy), but this would then require governments
ideologically committed to regulatory reform. This may
be difficult for a country like Guatemala, and for two
reasons.
First, and notwithstanding the ‘pink tide’ of govern-
ments in the late 1990s and early 2000s, and now in
some retreat [46], the LAC region spent years under
pro-liberalization and pro-privatization structural adjust-
ment programs and largely embraced neoliberal eco-
nomic policies associated with the past several decades
of globalization [47, 48]. It is hard to discuss regulatory
reform without addressing the political economy choices
governments have made (or had thrust upon them) in
the past, and which can strongly condition their future.
Second, and paralleling the first, Guatemala is just one
of several countries in the LAC region wanting to attract
international medical patients. If none of the other
countries similarly pursue regulation of the sector along
the lines proposed by Israel (which adds costs all round,
including to providers), Guatemala’s ‘good behaviour’
(should it adopt regulations like Israel’s) is likely to
disadvantage it competitively.
Global governance of medical tourism
That whole regions are now in competition with each
other in medical tourism begs the question: is there a
need for, or possibilities of, effective systems of
global-level governance to ensure that (a) medical tour-
ists are treated well, (b) local citizens’ health care access
improves, and (c) the allocation of economic benefits of
medical tourism disproportionately improves the in-
comes of poorer, marginalized populations, as called for
in the 2015 UN Sustainable Development Goals [49]?
There is little disagreement amongst academic scholars
that regulating medical tourism at a global level would
be preferable to a patchwork of national initiatives. The
case for international accreditation standards for medical
tourism facilities and practice has been well made and a
number of prescriptions argued, including oversight by a
major international or intergovernmental body [50].
Existing national governance structures and legal frame-
works on treatment and care standards would then need
to be harmonized with internationally agreed upon
quality standards, and enforced and maintained within
countries for both public and private providers [51].
There has been some suggestion of a new global gov-
ernance platform for medical tourism (under UN, World
Health Organization, or World Tourism Organization
auspices) to develop international codes of practice or a
framework convention based on a review of best regula-
tory practices [52]. Although such an effort might hold
normative power, even if crafted as a legal treaty (e.g. as
a framework convention) rather than as a voluntary
code, it would still lack sanctioning penalties. It would
also require a large number of countries to want such a
binding governance instrument. Such an effort would
also have to grapple with a number of contradictions
between existing international treaties. Guatemala, for
example, has made health services liberalization and
investment protection commitments under a number of
different treaties [33], with such commitments contra-
dicting obligations all countries have under international
human rights obligations, including the right to health
[53]. Although the right to health is also part of
Guatemala’s national constitution (and justiciable by its
own courts), the fulfilment of this right is undermined
by the parlous state of public health financing, on the
one hand, and by apparent governmental indifference,
on the other, with one of our informants complaining
that: “In reality the State responds to personal interests
(rather) than to the right to health…”.
Limitations
One important limitation in our study is that many
participants were providing forward-looking comments
in that medical tourism is nascent and still very limited
in Guatemala. In other words, they were discussing
anticipated concerns, issues, and benefits as opposed to
realized ones. Capturing these forward-looking com-
ments, however, is very useful, as they provide important
insight for interventions that can offset anticipated
harms; while identifying barriers and enablers to
health-equity oriented regulatory regimes.
Conclusions
Guatemalan attempts to grow its medical tourism sector
appears at this time to be largely in a regulatory vacuum.
Few if any of the of the health equity concerns raised by
existing literature appear have been addressed by the
country, with informants not terribly sanguine that they
will be in any short term. This does not minimize their
recognition of the importance for such regulation, a
concern for many of them that includes regulation of
the public health sector as well.
The primary role of regulation is to serve the public.
In the context of medical tourism, this extends to three
primary ‘publics’: the international patient, the citizens
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of the destination country, and the citizens of the inter-
national patient’s source country. As has been noted by
others, it is imperative for Guatemala and for other
nations engaged in developing this sector, to give med-
ical tourism much needed regulatory attention:
The rapid developments in medical tourism demands
have left the policing and legislation behind. It would
be imperative for this legislation to catch up in order
to protect the vulnerable that are unable to make
well-informed research-based decisions [10].
In a global context in which governance of inter-
national trade and financial liberalization is strong, and
global governance for health is undeveloped, the inter-
national trade regime might attenuate some of the policy
options national governments can or should be able to
pursue to improve regulation of health care within their
own borders [54–56].
The intersection of domestic and international regula-
tion of medical tourism has been largely unexplored. We
contend that in advancing new research is this area,
there is a need for studies and analyses to incorporate a
critical political economy approach. A political economy
analysis of medical tourism, for example, would draw at-
tention to how global inequalities in wealth and income
distribution create incentives for international patients
to seek care abroad, often with little regard for its distri-
butional impact on others. This is more obvious in cases
of ethically or legally dubious practices (notably organ
harvesting and transplantation) where the wealth of one
intersects with the poverty of others, and the pecuniary
interests of third-party private providers or foreign
currency-hungry governments, is creating outcomes that
are inequitable by almost any metric. There are more
nuanced aspects to the ethics and economics of many
other facets of medical tourism (e.g. fertility or surrogacy
tourism, abortion tourism, or simply the ‘crowding out’
of general public health care access); but this is not the
place to entertain a deep discussion of these concerns.
It is sufficient to issue a caution that underlying
medical tourism is the slow privatization of medical
care facilities worldwide [57]. Whether directly owned
and outside of any public system, or part of the
‘public-private partnership’ models that have been
promoted as short-term fixes for governments’ short-
falls in public revenues, the driving force of such
privatization is capital accumulation for the share-
holders or managerial class of transnational provider
corporations or investment funds [58]. What is left
unstated is that scarcity in government revenues
incentivizing such developments is an outcome of
several decades of global tax competition and the
privatization of public assets, eviscerating the ability
of most governments to provide equitably for public
goods such as public health care [47, 58].
Much of the global health policy attention is now fo-
cused on Universal Health Coverage (UHC), and likely
will be as the Sustainable Development Goals slowly
wind down to their 2030 endpoint. UHC remains a
problematic construct that has considerably less political
teeth than the more assertive 1978 Alma Ata Declar-
ation on Primary Health Care that UHC has come to
eclipse [59]. More policy time is now spent debating
how UHC might be financed to minimize the impover-
ishing out-of-pocket payments, including for many of
the citizens in Guatemala, than how health systems can
achieve health equitable outcomes incorporating policy
changes affecting not only medical care, but also the
social determinants of health [60]. But unless, and until,
the upwards distribution of global wealth (global
economic product) from public citizens to private
owners is reversed, along with the steep and ongoing
decline in overall tax rates that governments apply to
economic activities, it is unlikely that the medical tour-
ism (or broader health system) regulatory shortcomings
in countries like Guatemala will be resolved.
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